Cellular Technology Limited CTL Revenue and Competitors

Shaker Heights, OH USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cellular Technology Limited CTL's estimated annual revenue is currently $22.6M per year.(i)
  • Cellular Technology Limited CTL's estimated revenue per employee is $155,000

Employee Data

  • Cellular Technology Limited CTL has 146 Employees.(i)
  • Cellular Technology Limited CTL grew their employee count by 8% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$119.4M659N/AN/AN/A
#2
$168.6M860N/AN/AN/A
#3
$142.9M704N/AN/AN/A
#4
$1260.2M3138-6%$511.5MN/A
#5
$1.5M17N/AN/AN/A
#6
$5M32N/AN/AN/A
#7
$157.9M77831%N/AN/A
#8
$281.5M1135-7%$411.9M$6.1B
#9
$4.2M36N/AN/AN/A
#10
$229.8M681N/AN/AN/A
#11
$12.6M52N/AN/AN/A
#12
$0.4M6N/AN/AN/A
#13
$2.2M22N/AN/AN/A
#14
$7.6M49N/AN/AN/A
#15
$2M20N/AN/AN/A
#16
$5M432%N/AN/A
#17
$13.6M54N/AN/AN/A
#18
$5.5M47N/AN/AN/A
#19
$640.7M1868N/AN/AN/A
#20
$2.7M27N/AN/AN/A
Add Company

Cellular Technology Limited (CTL) has been pioneering the ELISPOT technology for immune monitoring. For nearly 20 years, CTL's mission has been Elevating ELISPOT to an Exact Science. Serving over 2,000 clients from academia and industry worldwide, CTL offers unparalleled expertise in immune monitoring. We offer: Contract Laboratory: Immune monitoring with an emphasis on T and B cells in a CLIA-certified, GLP-compliant laboratory with processing capabilities of up to 450 samples per week. Assays include: ELISPOT, ELISA, FACS, CBA, Proliferation, and more. Comprehensive solutions for sample processing: Whole blood processing with optimized PBMC cryopreservation methods that ensure good cell functionality. All-around ELISPOT including: Protocols and reagents for human PBMC cryopreservation, processing, and testing Human PBMC reference samples as reference standards for assay performance. Extensive Cryopreserved PBMC Library: The largest commercially available library of donors available both uncharacterized and with established T cell reactivity. ImmunoSpot® Kits: Standardized T Cell and B Cell ELISPOT Kits. Single- and Double-color Enzymatic ELISPOT. Up to Four-color T Cell & B Cell FluoroSpot Kits. Cytokine/Antibody combination multicolor FluoroSpot Kits. Non-radioactive human Natural Killer/ADCC Assessment Kits Positive and negative control antigens. Consultation and Hands-on Workshop Training on the use of ELISPOT for immune monitoring. ImmunoSpot® Analyzers for automated and objective ELISPOT data analysis and streamlined data processing with audit trails. BioSpot® Analyzers for serum antibody neutralization tests; Viral Plaque, PRNT, Viral ICA, Serum Neutralization Assays, and Serum Bactericidal Assays, all with multicolor capability. Serum-free Media for washing, testing, and freezing PBMC Plate Scanning and Analysis Services

keywords:Biotechnology,Healthcare,Medical Diagnostics

N/A

Total Funding

146

Number of Employees

$22.6M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cellular Technology Limited CTL News

2022-04-19 - Reprogramming a new type of T cell to go after cancers with ...

Immunotherapy is one of the more appealing and effective kinds of cancer treatment when it works, but the relatively new approach is still fairly limited in...

2022-04-06 - Hope for stroke? Protein could limit damage by shielding parts ...

The researchers did caution that their work is limited by a small sample ... produce pretty dramatic increases in sensitivity to CTL attach.

2022-03-22 - SARS-CoV-2 Omicron Variant is Expected to Retain Most of ...

Funding: Supported by Guangzhou Science and Technology Innovation Committee ... although limited mutations were found within dominant CTL...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$32.3M196N/AN/A
#2
$57.7M2140%N/A
#3
$41.4M2150%N/A
#4
$24.9M226N/AN/A
#5
$51.7M22921%N/A